Mereo BioPharma Group plc
MREO
$0.32
$0.013.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.60% | -4.66% | 51.94% | -13.42% | -82.90% |
| Total Depreciation and Amortization | -48.48% | 5,481.82% | -103.69% | 10.37% | -1.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -104.46% | 296.29% | -108.97% | 56.39% | 237.00% |
| Change in Net Operating Assets | 196.22% | -661.50% | 147.45% | -64.01% | -159.98% |
| Cash from Operations | 43.87% | -5.10% | 4.47% | 8.14% | 11.58% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -- | 100.00% | -- |
| Cash from Investing | -- | -100.00% | -- | 100.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -106.15% | -62.50% |
| Cash from Financing | -- | -- | 100.00% | -131.75% | 1,155.00% |
| Foreign Exchange rate Adjustments | -149.21% | 84.93% | -129.29% | 57.16% | 172.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.11% | -3.76% | -16.81% | 13.13% | 31.73% |